Cleantech start-up DePoly is behind an innovative solution to the plastics challenge facing the world today.
Based at the Energypolis Campus in Sion and supported by The Ark Foundation, DePoly is now building its demonstration plant on the Monthey chemical site and extending its activities to the BioArk Monthey technology site to follow the construction work.
Regen Lab’s patented technology revolutionises blood component separation using thixotropic gel. Our kits undergo rigorous biocompatibility and safety testing, and are designed, manufactured, and packaged according to European and international standards.
They meet the requirements of the European Medical Device Directive 93/42/EEC and the European Medical Device Regulation 2017/745.
Regen Lab kits are CE certified and have clearance in multiple countries, including the USA, Canada, Australia, and China.
Bioscibex is at the forefront of biopharmaceutical innovation, providing cutting-edge bioreactor technologies that simplify and automate cell-based therapies. We aim to accelerate and reduce the cost of drug development and manufacturing, making breakthrough treatments accessible to all and improving global health and longevity. Our single-use bioreactor simplifies cell culture with automation and closed system, accommodating volumes from 30 mL to 30 L in the same vessel. It is designed for a broad range of cells. Our technology offers an unmatched scalability (bioreactor’s 1000:1 turndown ratio), advanced sensors, modularity and a proven technology.
Ninsun Biotech is developing the missing biomarker for immunotherapy decision-making in Non Small Cell Lung Cancer.
While immunotherapy is dramatically improving survival, yet up to 80% of patients fail to respond.
By specifically detecting Cancer Stem Cells directly in tumor tissue through a standard IHC test, NinStem Lung™ aims to identify patients unlikely to respond to immunotherapy, improving outcomes while reducing unnecessary toxicity and healthcare costs.
Entering clinical development toward CE IVDR, NinStem Lung™ is designed to complement PD-L1 testing and help clinicians in their decision to treat.
The company targets a market of more than 400,000 tests annually across Europe and the US.
We predict the right treatment at the right time.
The Argentine company specializes in the development of microfluidic systems for biomanufacturing.
Specializes in the R&D sector and the production of kits, reagents as well as laboratory equipment (immunodiagnostics).
Wama Diagnostics (Switzerland) SA Read More »
Yoni Solutions is an healthcare company which aims at improving the results in vaginal microbiome analysis that are linked to the fertility of women, in order to increase the success rates of In Vitro Fertilisation.
Engineering group for design, construction of Pharma, Bio, Chemical manufacturing plants and waste water treatment plants
Ceidos has developed a machine that automates the production of cell therapies, which are used in particular as a treatment for cancer.
